Results 221 to 230 of about 8,624 (295)

A Geomagnetic Estimate of Heliospheric Modulation Potential over the Last 175 Years. [PDF]

Sol Phys
Owens MJ, Barnard LA, Muscheler R, Herbst K, Lockwood M, Usoskin I, Asvestari E.   +6 more
europepmc   +1 more source

Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta‐analysis

Acta Ophthalmologica, Volume 104, Issue 4, Page 355-363, June 2026.
Abstract Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.
I. Made Ferdiko Hutamadella, Emil Ørnberg, Mark P. Breazzano, Lasse Jørgensen Cehofski, Chui Ming Gemmy Cheung, Kristina Pfau, M. Cem Sabaner, Lorenzo Ferro Desideri, Camiel J. F. Boon, Yousif Subhi, Elon H. C. van Dijk   +10 more
wiley   +1 more source

Evaluating solar-like behavior in turbulent alpha and Babcock-Leighton mechanisms using non-kinematic nonlinear flux-transport solar dynamos. [PDF]

Sci Rep
Inceoglu F, Arlt R.
europepmc   +1 more source

Advancing Brain and Body Vascular Imaging in Bipolar Disorder: A Report From the International Society for Bipolar Disorders Vascular Task Force

Bipolar Disorders, Volume 28, Issue 4, June 2026.
ABSTRACT Objectives The heart–brain nexus is increasingly recognized as important for human health. Nonetheless, integration of this perspective in research and treatment remains limited in psychiatry, particularly in bipolar disorder (BD). Multisystem vascular imaging may help elucidate mechanisms linking heart and brain health in BD.
Megan Mio, Pao‐Huan Chen, Kody G. Kennedy, Hilary P. Blumberg, David J. Bond, Eric L. Goldwaser, Fabiano A. Gomes, Jody L. Greaney, Tomas Hajek, Susan L. McElroy, Roger S. McIntyre, Abigail Ortiz, Miguel L. Prieto, Elysha Ringin, Louisa G. Sylvia, Shang‐Ying Tsai, Jess G. Fiedorowicz, Benjamin I. Goldstein   +17 more
wiley   +1 more source

Advanced CRISPR Technologies for RNA Imaging in Live Cells. [PDF]

Chem Biomed Imaging
Lv X, Li Z, Zheng H, Sun T, Xie W, Yuan A, Shang Y, Peng H.   +7 more
europepmc   +1 more source

Oral Angiolymphoid Hyperplasia With Eosinophilia Exhibiting Cutaneous‐Type Histopathologic Features: Clinical Regression Following Hormonal Withdrawal and a 50‐Year Review

Journal of Cutaneous Pathology, Volume 53, Issue 6, Page 491-501, June 2026.
Case report of a 30‐year‐old female. Asymptomatic, red‐purple hyperplastic lesion extending from teeth 21 to 25, with bleeding upon manipulation. Differential diagnosis included: inflammatory gingival hyperplasia, plasma cell gingivitis, leukemia, and Wegener's granulomatosis.
Pedro Vinícius Santos de Jesus, Louise Cristina Santos, Gilberth Tadeu Dos Santos Aciole, John Lennon Silva Cunha, Nicole Lonni, Matheus Antoni da Silva Costa, Elena Riet Correa Rivero, Rogério Gondak, Ricardo Luíz Cavalcanti de Albuquerque‐Júnior   +8 more
wiley   +1 more source

Solar forcing on elemental and nanomechanical variations in Late Cretaceous lacustrine deposits. [PDF]

Sci Rep
Liu Y, Wang X, Cui K, Wu M, Qi X, Zhang S.   +5 more
europepmc   +1 more source

Ophthalmic Vascular Occlusion and Blindness After Platelet‐Rich Plasma Injections: A Systematic Review

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Platelet‐rich plasma (PRP) is widely used in aesthetic and regenerative medicine; however, rare vision‐threatening complications such as blindness have been reported following facial injections. Aims This systematic review aimed to identify and analyze all published cases of visual impairment following PRP injections.
Mandana Ebrahimzade, Shahriar Nazari, Mohammad Reza Pourani, Cristina Muñoz‐Gonzalez, Fahimeh Abdollahimajd, Maurizio Cavallini, Nabil Fakih‐Gomez   +6 more
wiley   +1 more source

Double Decomposition and Fuzzy Cognitive Graph-Based Prediction of Non-Stationary Time Series. [PDF]

Sensors (Basel)
Chen J, Guan A, Cheng S.
europepmc   +1 more source

Acute GLP‐1 infusion in male adults lowers circulating angiotensin II without changing angiotensinogen, ACE, ACE2, or angiotensin‐(1–7) concentrations

Physiological Reports, Volume 14, Issue 11, June 2026.
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists elicit cardiovascular and renal protection. In humans, GLP‐1 reduces plasma angiotensin II (ANGII) and increases renal perfusion, leading to increased natriuresis. The mechanisms underlying suppression of ANGII remain unclear but may involve ACE2 activation and/or a decrease in angiotensinogen.
Ali Asmar, Muskaan Akram, Charlotte M. Sorensen, Jesper K. Andresen, Boye L. Jensen   +4 more
wiley   +1 more source